BHC
BHC
NYSE · Pharmaceuticals

Bausch Health Cos Inc

$8.15
+0.19 (+2.39%)
As of Nov 7, 1:36 AM ET ·
Analyst Consensus
Strong Sell
8
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 50%
Sell 4 50%
Price Target
Analyst Price Target +1,173.4% upside
Low Target $65.08
Average Target $103.78
High Target $115.24
Current Price $8.15
Current
$8.15
Target
$103.78
$65.08 $103.78 avg $115.24
Scenario Analysis
Bear Case
$65.08
698.5%
Low target
Base Case
$103.78
+1,173.4%
Avg target
Bull Case
$115.24
+1,314.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$12.65
-35.6% from high
52-Week Low
$6.10
+33.6% from low
50-Day SMA
$6.40
+27.3% vs SMA
200-Day SMA
$5.73
+42.2% vs SMA
RSI (14)
69.5
Neutral
Target vs 52W High
$103.78
+720.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%